StonvexLoading…
StonvexStonvexStonvexCore line items from GRND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $129.94M | $439.90M | $313.92M | $198.16M |
Operating Income | $42.73M | $126.29M | $94.98M | $49.74M |
Net Income | $26.75M | $94.75M | $74.49M | $16.64M |
EPS (Diluted) | $0.14 | $0.43 | $0.33 | $0.17 |
Total Assets | $470.92M | $531.03M | $439.19M | $547.62M |
Total Liabilities | $470.08M | $484.02M | $368.23M | $359.93M |
Cash & Equivalents | $23.81M | $87.05M | $6.33M | $120.83M |
Free Cash Flow OCF − CapEx | $33.43M | $140.77M | $116.24M | $60.99M |
Shares Outstanding | 177.20M | 185.03M | 184.50M | 193.32M |